메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

SK bioscience, IDT Biologika and Vaxxas Selected for Next-Generation Influenza Vaccine development Financed by the European Union

SK–IDT–Vaxxas consortium establishes strategic entry point for high-density microarray patch (HD-MAP) vaccines in Europe to improve vaccine performance and access. Parallel development of high-immunogenicity HD-MAP vaccines for seasonal and pandemic influenza threats. INCHEON, South Korea, Feb. 26, 2026 -- SK bioscience announced that, together with IDT Biologika (IDT) and Australian biotechnology company Vaxxas, it has been selected for Phase 1 of a next-generation vaccine development initiative managed by the European Health and Digital Executive Agency (HaDEA) on beha
- 김갑성 기자
- 2026-02-26 21:00
CJ BIO Publishes Clinical Study on BiomeNrich™ POST SZ075, a Postbiotic Ingredient Demonstrating Skin Improvement Benefits

SEOUL, South Korea, Feb. 26, 2026 -- CJ BIO announced the publication of clinical research findings on its postbiotic ingredient, BiomeNrich™ POST SZ075, in an international peer-reviewed journal. The study strengthens the scientific foundation of the ingredient and supports its positioning as a science-based inner beauty solution. Growing Importance of Scientific Validation in the Inner Beauty Market The global beauty and personal care market is rapidly shifting toward "Beauty from within" approaches that improve skin condition through internal health
- 김갑성 기자
- 2026-02-26 18:40
HealthTech Partners Global Expands Clinical Education Division and Appoints Strategic Advisor Rusty Page Under Leadership of Former DIH Commercial VP Allison Krumpe

RICHMOND, Va., Feb. 26, 2026 -- HealthTech Partners Global today announced a major expansion of its international clinical education division, alongside the appointment of strategic advisor Rusty Page, whose expertise in operations, quality, and IT will strengthen the company's global infrastructure. Under the leadership of former DIH Commercial Vice President of North America & Asia Pacific, Allison Krumpe, the organization is evolving from a commercial consulting and service-focused model into a comprehensive rehabilitation solutions provider, providing end-to-end support across
- 김갑성 기자
- 2026-02-26 18:05
Health Awareness Week Underscores the Importance of Respiratory Health

NEW YORK, Feb. 26, 2026 -- As Health Awareness Week brings focus to preventive care and chronic condition management, VARON is highlighting the vital role respiratory health plays in overall well-being. Through its "Your Health, Our Commitment" initiative, the company is promoting greater awareness of breathing health while expanding access to supportive solutions for individuals managing long-term respiratory needs. While cardiovascular health and metabolic conditions often dominate public discussion, respiratory health remains a foundational—yet freque
- 김갑성 기자
- 2026-02-26 16:42
genOway: Revolutionizing the Prediction of Antibody Therapies in Humans with Unique Mouse Model

LYON, France, Feb. 26, 2026 -- Antibody therapies are changing the treatment of cancer, inflammatory diseases and infections. However, many promising drug candidates fail in clinical trials. A study in Science Immunology shows that genOway's genO-hFcγR mouse model enables more accurate prediction of therapeutic antibody efficacy and safety. Why Antibody Therapies Fail in Late-Stage Testing Antibody therapies work in part by binding to Fcγ receptors, proteins found on immune cells that control key immune functions such as antibody-mediated cell killing and inflamm
- 김갑성 기자
- 2026-02-26 16:15
BC30™ Approved for "Live Culture" Claim in Indonesia, Opening Opportunities in F&B Innovation

JAKARTA, Indonesia, Feb. 26, 2026 -- Kerry's BC30™ (Bacillus coagulans GBI‑30, 6086), a resilient, spore‑forming probiotic ingredient, has received regulatory approval in Indonesia for use with the "Live Culture" claim across applicable general food categories. The approval follows the inclusion of BC30™ in Indonesia's permitted microorganism list under PERBPOM No. 38/2023, which defines the microorganisms permitted for use in processed foods in Indonesia. Products containing BC30™ may communicate "Live Culture" on pack and in marketing communication
- 김갑성 기자
- 2026-02-26 14:02
Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics

[ 메디채널 김갑성 기자 ] At AGBT, researchers reveal new findings from studies leveraging Illumina's multiomics solutions SAN DIEGO, Feb. 26, 2026 -- Illumina, Inc. (NASDAQ: ILMN) announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, 5-base sequencing, and proteomics technologies. The ability to combine more than one omic insight reveals unprecedented biological depth and knowledge, all of which is streamlined by Illumina Connected Multiomics for multimodal data analysis. The combined portfolio delivers new insights for precision diagnostics, targete
- 김갑성 기자
- 2026-02-26 13:54
Illumina launches TruPath Genome, setting a new standard in genomic insight

[ 메디채널 김갑성 기자 ] TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow Data presented at AGBT demonstrates TruPath Genome's accuracy in detecting rare genetic disease Broad Clinical Labs is among first to adopt product, which was previously known as "constellation mapped read technology" SAN DIEGO, Feb. 25, 2026 -- Illumina, Inc. (NASDAQ: ILMN) today announced the launch of TruPath™ Genome, setting a new standard for high-quality, comprehensive whole genome insights for genetic disease. TruPath Genome has been found to deliver unpa
- 김갑성 기자
- 2026-02-25 23:06
Canadian hospital now ranked #2 in the world

[ 메디채널 김갑성 기자 ] UHN achieves highest-ever position in Newsweek's World's Best Hospitals ranking TORONTO, Feb. 25, 2026 -- University Health Network's Toronto General Hospital has ranked second in the world in Newsweek magazine's World's Best Hospitals 2026, marking the highest position ever achieved by a Canadian hospital. This also marks the eighth consecutive year that University Health Network has been ranked as the world's #1 universally accessible hospital. UHN's Toronto Western Hospital and Princess Margaret Cancer Centre were also recognized in the annual ranking of t
- 김갑성 기자
- 2026-02-25 22:23
Discovery linking gut bacteria to cancer treatment wins the Bial Award in Biomedicine and earns €350,000 prize

A study published in Science reveals that a healthy gut microbiota can enhance the efficacy of immunotherapy used to treat cancer, while antibiotics may impair its effect by reducing intestinal microbiota diversity. PORTO, Portugal, Feb. 25, 2026 -- An international consortium of 48 researchers from institutions in France, Sweden, and the United States has won the 2025 edition of the Bial Award in Biomedicine, a €350,000 prize promoted by the Bial Foundation to recognise a published work of exceptional quality and scientific relevance in the field of biomedicine.
- 김갑성 기자
- 2026-02-25 22:00

이전

1 2 3 4 5 6 7 8 9 10

많이 본 기사

최근기사

2026-03-02_MON

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 03월 02일 23시 00분